Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiopharmaceuticals | 6 | 2009 | 114 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 3 | 2011 | 511 | 0.350 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 7 | 2014 | 137 | 0.340 |
Why?
|
| Technetium Tc 99m Exametazime | 3 | 2013 | 9 | 0.300 |
Why?
|
| Whole-Body Counting | 1 | 2007 | 6 | 0.300 |
Why?
|
| Radionuclide Imaging | 15 | 2013 | 166 | 0.270 |
Why?
|
| Positron-Emission Tomography | 4 | 2011 | 160 | 0.270 |
Why?
|
| Indium Radioisotopes | 3 | 2011 | 19 | 0.250 |
Why?
|
| Ubiquinone | 2 | 2012 | 14 | 0.210 |
Why?
|
| Mitochondrial Diseases | 2 | 2012 | 24 | 0.200 |
Why?
|
| Seizures | 2 | 2014 | 279 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 3 | 2014 | 296 | 0.180 |
Why?
|
| Teleradiology | 1 | 1999 | 5 | 0.170 |
Why?
|
| Cerebral Infarction | 1 | 1999 | 103 | 0.160 |
Why?
|
| Radionuclide Generators | 1 | 1998 | 6 | 0.160 |
Why?
|
| Particle Accelerators | 1 | 1998 | 10 | 0.160 |
Why?
|
| Tritium | 1 | 1998 | 101 | 0.160 |
Why?
|
| Pentetic Acid | 1 | 1997 | 18 | 0.140 |
Why?
|
| Octreotide | 1 | 1997 | 21 | 0.140 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1996 | 24 | 0.140 |
Why?
|
| Parathyroid Glands | 1 | 1996 | 22 | 0.140 |
Why?
|
| Technetium | 7 | 2011 | 38 | 0.140 |
Why?
|
| Phosphorus | 1 | 1996 | 64 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 2324 | 0.130 |
Why?
|
| Iodine Radioisotopes | 3 | 2000 | 119 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 346 | 0.120 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 5 | 1990 | 9 | 0.110 |
Why?
|
| Skin | 1 | 1996 | 451 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 1999 | 561 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 22 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2009 | 81 | 0.100 |
Why?
|
| Biliary Dyskinesia | 1 | 2011 | 7 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2011 | 13 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2011 | 24 | 0.100 |
Why?
|
| Middle Aged | 18 | 2013 | 21147 | 0.100 |
Why?
|
| Adult | 19 | 2013 | 21403 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 1753 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2011 | 62 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2013 | 138 | 0.100 |
Why?
|
| Erythrocytes | 4 | 1997 | 137 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2012 | 220 | 0.090 |
Why?
|
| Humans | 32 | 2014 | 68618 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 181 | 0.090 |
Why?
|
| Thallium Radioisotopes | 1 | 1990 | 13 | 0.090 |
Why?
|
| Dobutamine | 1 | 1990 | 25 | 0.090 |
Why?
|
| Radiology Information Systems | 2 | 2000 | 21 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 1990 | 94 | 0.090 |
Why?
|
| Female | 22 | 2012 | 38074 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2007 | 125 | 0.080 |
Why?
|
| Fasting | 1 | 2009 | 75 | 0.080 |
Why?
|
| Electroconvulsive Therapy | 1 | 2014 | 402 | 0.080 |
Why?
|
| Male | 21 | 2014 | 37321 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2009 | 77 | 0.080 |
Why?
|
| Brain | 4 | 2012 | 2176 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 2077 | 0.080 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2008 | 7 | 0.080 |
Why?
|
| Prefrontal Cortex | 3 | 2014 | 640 | 0.080 |
Why?
|
| Aged | 12 | 2014 | 14862 | 0.080 |
Why?
|
| Coronary Disease | 1 | 1990 | 358 | 0.080 |
Why?
|
| Imino Acids | 2 | 2011 | 7 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 167 | 0.070 |
Why?
|
| Thyroid Neoplasms | 2 | 1999 | 68 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 121 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 500 | 0.070 |
Why?
|
| Indomethacin | 1 | 1986 | 107 | 0.060 |
Why?
|
| Capillary Permeability | 6 | 1991 | 69 | 0.060 |
Why?
|
| Depressive Disorder, Major | 2 | 2001 | 439 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 778 | 0.060 |
Why?
|
| Dexamethasone | 1 | 1986 | 150 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 201 | 0.060 |
Why?
|
| Gastroparesis | 1 | 2004 | 7 | 0.060 |
Why?
|
| Oleic Acids | 4 | 1989 | 40 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 2004 | 31 | 0.060 |
Why?
|
| Perfusion | 2 | 2014 | 131 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 629 | 0.050 |
Why?
|
| Catheterization | 1 | 1983 | 209 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 8912 | 0.050 |
Why?
|
| Organotechnetium Compounds | 1 | 2001 | 4 | 0.050 |
Why?
|
| Sincalide | 1 | 2001 | 12 | 0.050 |
Why?
|
| Common Bile Duct | 1 | 2001 | 22 | 0.050 |
Why?
|
| Limbic System | 2 | 1999 | 106 | 0.050 |
Why?
|
| Gastrointestinal Agents | 1 | 2001 | 51 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2013 | 3187 | 0.050 |
Why?
|
| Hemangioma | 1 | 1981 | 51 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 1983 | 253 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2000 | 4 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2001 | 163 | 0.050 |
Why?
|
| Health Physics | 1 | 2000 | 14 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2001 | 66 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2000 | 36 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2004 | 301 | 0.050 |
Why?
|
| Radiology Department, Hospital | 1 | 2000 | 10 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2008 | 446 | 0.040 |
Why?
|
| Hospital Design and Construction | 1 | 2000 | 13 | 0.040 |
Why?
|
| Fatty Acids, Essential | 2 | 1990 | 16 | 0.040 |
Why?
|
| Shock, Septic | 2 | 1990 | 101 | 0.040 |
Why?
|
| Technology, Radiologic | 1 | 1999 | 7 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 1140 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2001 | 147 | 0.040 |
Why?
|
| Electromagnetic Phenomena | 1 | 1999 | 25 | 0.040 |
Why?
|
| Remote Consultation | 1 | 1999 | 50 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 1999 | 85 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 193 | 0.040 |
Why?
|
| Thromboxane B2 | 3 | 1991 | 108 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2001 | 307 | 0.040 |
Why?
|
| Radioisotopes | 1 | 1998 | 40 | 0.040 |
Why?
|
| Carcinoma | 1 | 1999 | 215 | 0.040 |
Why?
|
| Time Factors | 5 | 1999 | 4655 | 0.040 |
Why?
|
| Liver | 2 | 2001 | 1118 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 1999 | 182 | 0.040 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1997 | 2 | 0.040 |
Why?
|
| Ventriculography, First-Pass | 1 | 1997 | 3 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 1981 | 375 | 0.040 |
Why?
|
| Child | 3 | 2013 | 6405 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1997 | 7 | 0.040 |
Why?
|
| Parathyroid Neoplasms | 1 | 1996 | 13 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1997 | 54 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1996 | 89 | 0.030 |
Why?
|
| Endotoxins | 3 | 1991 | 76 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2011 | 3705 | 0.030 |
Why?
|
| Phosphocreatine | 1 | 1996 | 20 | 0.030 |
Why?
|
| Meningioma | 1 | 1997 | 54 | 0.030 |
Why?
|
| Artifacts | 1 | 1996 | 125 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1999 | 435 | 0.030 |
Why?
|
| Malonates | 1 | 1995 | 4 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1040 | 0.030 |
Why?
|
| Adenoma | 1 | 1996 | 132 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1988 | 244 | 0.030 |
Why?
|
| Serum Albumin | 5 | 1990 | 104 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 333 | 0.030 |
Why?
|
| SRS-A | 3 | 1990 | 20 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1995 | 137 | 0.030 |
Why?
|
| Xenon Radioisotopes | 2 | 1985 | 6 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 1996 | 189 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2008 | 168 | 0.030 |
Why?
|
| Lung | 4 | 1990 | 849 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 314 | 0.030 |
Why?
|
| Image Enhancement | 2 | 2009 | 143 | 0.030 |
Why?
|
| Butanones | 1 | 1992 | 1 | 0.030 |
Why?
|
| Ethanol | 1 | 1999 | 893 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 396 | 0.030 |
Why?
|
| Leukotriene B4 | 2 | 1989 | 17 | 0.030 |
Why?
|
| Oleic Acid | 3 | 1988 | 40 | 0.030 |
Why?
|
| Gallbladder Emptying | 1 | 2011 | 4 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 279 | 0.030 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 1991 | 42 | 0.030 |
Why?
|
| Oximes | 1 | 2011 | 10 | 0.030 |
Why?
|
| Seminal Vesicles | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 2011 | 29 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4848 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 418 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5717 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 161 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 67 | 0.020 |
Why?
|
| Linseed Oil | 1 | 1991 | 2 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1991 | 8 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.020 |
Why?
|
| Smoking | 1 | 1999 | 1452 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 168 | 0.020 |
Why?
|
| Rabbits | 2 | 1995 | 509 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2014 | 342 | 0.020 |
Why?
|
| Prostate | 1 | 2011 | 116 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 1991 | 50 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 240 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1991 | 40 | 0.020 |
Why?
|
| Alcoholism | 1 | 1999 | 1109 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 173 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 306 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1990 | 72 | 0.020 |
Why?
|
| Spinal Cord Injuries | 2 | 1988 | 551 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 1990 | 56 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 786 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2009 | 12 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 453 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2673 | 0.020 |
Why?
|
| Lung Injury | 1 | 1989 | 38 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2012 | 532 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 627 | 0.020 |
Why?
|
| Rats | 7 | 1991 | 5300 | 0.020 |
Why?
|
| Body Constitution | 1 | 1988 | 24 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 1988 | 37 | 0.020 |
Why?
|
| Menstruation | 1 | 1988 | 20 | 0.020 |
Why?
|
| Minerals | 1 | 1988 | 43 | 0.020 |
Why?
|
| Blood Volume | 1 | 2008 | 47 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 595 | 0.020 |
Why?
|
| Animals | 10 | 1995 | 20881 | 0.020 |
Why?
|
| Sodium Pertechnetate Tc 99m | 2 | 1992 | 5 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 172 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 219 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1988 | 145 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1988 | 102 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 718 | 0.020 |
Why?
|
| Depression | 1 | 2014 | 943 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 902 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 2891 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2001 | 1738 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 2358 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 7029 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1293 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1985 | 168 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1986 | 175 | 0.020 |
Why?
|
| Thromboxanes | 1 | 1984 | 53 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 1342 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 24 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1986 | 649 | 0.010 |
Why?
|
| Blood Coagulation | 2 | 1997 | 123 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1983 | 37 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 1983 | 23 | 0.010 |
Why?
|
| Knee | 1 | 1983 | 17 | 0.010 |
Why?
|
| Arthritis, Infectious | 1 | 1983 | 14 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1983 | 53 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2004 | 1451 | 0.010 |
Why?
|
| Aniline Compounds | 1 | 2001 | 52 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 568 | 0.010 |
Why?
|
| Sphincter of Oddi | 1 | 2001 | 51 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 2001 | 79 | 0.010 |
Why?
|
| Abdomen | 1 | 1981 | 80 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1981 | 57 | 0.010 |
Why?
|
| Glycine | 1 | 2001 | 89 | 0.010 |
Why?
|
| Angiography | 1 | 1981 | 194 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 330 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2001 | 65 | 0.010 |
Why?
|
| Salmonella enteritidis | 2 | 1990 | 24 | 0.010 |
Why?
|
| Risk Factors | 1 | 1990 | 5731 | 0.010 |
Why?
|
| Acetophenones | 2 | 1990 | 12 | 0.010 |
Why?
|
| Outpatients | 1 | 2000 | 127 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2000 | 62 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 100 | 0.010 |
Why?
|
| Tetrazoles | 2 | 1990 | 160 | 0.010 |
Why?
|
| Skull | 1 | 1999 | 63 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 420 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1999 | 125 | 0.010 |
Why?
|
| Kinetics | 2 | 1990 | 1047 | 0.010 |
Why?
|
| Tin Polyphosphates | 1 | 1997 | 1 | 0.010 |
Why?
|
| Gamma Cameras | 1 | 1997 | 1 | 0.010 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 1997 | 1 | 0.010 |
Why?
|
| Tin Compounds | 1 | 1997 | 1 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 216 | 0.010 |
Why?
|
| Syringes | 1 | 1997 | 15 | 0.010 |
Why?
|
| Drug Stability | 1 | 1997 | 71 | 0.010 |
Why?
|
| Centrifugation | 1 | 1997 | 16 | 0.010 |
Why?
|
| Hemolysis | 1 | 1997 | 39 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2009 | 7277 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 442 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1988 | 532 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1995 | 48 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 282 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 1851 | 0.010 |
Why?
|
| Drug Storage | 1 | 1992 | 16 | 0.010 |
Why?
|
| Quality Control | 1 | 1992 | 81 | 0.010 |
Why?
|
| Mesentery | 1 | 1991 | 17 | 0.010 |
Why?
|
| Receptors, Leukotriene | 1 | 1990 | 8 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 1990 | 11 | 0.010 |
Why?
|
| Dicarboxylic Acids | 1 | 1990 | 16 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 1173 | 0.010 |
Why?
|
| Hematocrit | 1 | 1990 | 70 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1992 | 652 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1991 | 222 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1989 | 41 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1989 | 94 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1989 | 164 | 0.010 |
Why?
|
| Platelet Count | 1 | 1989 | 100 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1989 | 63 | 0.010 |
Why?
|
| Permeability | 1 | 1989 | 131 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1989 | 117 | 0.010 |
Why?
|
| Dimercaprol | 1 | 1988 | 3 | 0.010 |
Why?
|
| Leukotriene E4 | 1 | 1988 | 6 | 0.010 |
Why?
|
| Leukopenia | 1 | 1988 | 23 | 0.010 |
Why?
|
| Radius | 1 | 1988 | 10 | 0.000 |
Why?
|
| Hip | 1 | 1988 | 19 | 0.000 |
Why?
|
| Spine | 1 | 1988 | 46 | 0.000 |
Why?
|
| Macrophages | 1 | 1991 | 647 | 0.000 |
Why?
|
| Oxygen | 1 | 1988 | 386 | 0.000 |
Why?
|
| Homeostasis | 1 | 1988 | 291 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1988 | 737 | 0.000 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1985 | 8 | 0.000 |
Why?
|
| Water | 1 | 1985 | 230 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1984 | 121 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 105 | 0.000 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1983 | 3 | 0.000 |
Why?
|
| Dogs | 1 | 1984 | 490 | 0.000 |
Why?
|
| Diphosphonates | 1 | 1983 | 39 | 0.000 |
Why?
|
| Calcium | 1 | 1985 | 929 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1984 | 705 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1984 | 1745 | 0.000 |
Why?
|